drugset / Trial / NCT01202084

A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients

NCT01202084

Phase 3 Completed 222 enrolled Eurofarma Laboratorios S.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective will be to compare the impact of the study formulations on pulmonary function in persistent asthma carriers.

Timeline

Start
2012-01
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 400 ug
Comparator Fluticasone Other / unclassified 250 ug
Comparator Fluticasone Other / unclassified 500 ug
Subject Formoterol Other / unclassified 12 ug

Indications